The relationship between the pharmacokinetics (PK) and the pharmacodynamics (PD) of a product influence its efficacy. The PK/PD relationship of Pharmasin® / Tylovet® (tylosin phosphate) was examined in two trials, one conducted in Brazil and the other in Italy. In both trials the colon content concentrations (CCC) of tylosin were found to be high, exceeding the MIC values of the majority of the Clostridium perfringens strains.
The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.
To view all products and services, select Global from the dropdown menu or click .
Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.
Update your browser to view this website correctly. Update my browser now